SCIB Stock Overview
A medical technology company, develops and sells point-of-care platforms that utilizes electrical impedance spectroscopy for the evaluation of skin disorders in Europe, the United States, North America, Asia, Oceania, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 2 more risks
SciBase Holding AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.48 |
| 52 Week High | SEK 1.12 |
| 52 Week Low | SEK 0.23 |
| Beta | 1.51 |
| 11 Month Change | -4.80% |
| 3 Month Change | -11.85% |
| 1 Year Change | -49.36% |
| 33 Year Change | -91.90% |
| 5 Year Change | -90.67% |
| Change since IPO | -99.00% |
Recent News & Updates
Recent updates
Is SciBase Holding (STO:SCIB) In A Good Position To Deliver On Growth Plans?
Sep 03
Will SciBase Holding (STO:SCIB) Spend Its Cash Wisely?
May 05We're Hopeful That SciBase Holding (STO:SCIB) Will Use Its Cash Wisely
Oct 12Is SciBase Holding (STO:SCIB) In A Good Position To Deliver On Growth Plans?
Mar 30Calculating The Intrinsic Value Of SciBase Holding AB (publ) (STO:SCIB)
Dec 12Shareholder Returns
| SCIB | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | -6.7% | -4.8% | -1.4% |
| 1Y | -49.4% | 5.6% | 20.7% |
Return vs Industry: SCIB underperformed the Swedish Medical Equipment industry which returned 10.2% over the past year.
Return vs Market: SCIB underperformed the Swedish Market which returned 25.9% over the past year.
Price Volatility
| SCIB volatility | |
|---|---|
| SCIB Average Weekly Movement | 12.6% |
| Medical Equipment Industry Average Movement | 7.2% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in SE Market | 10.9% |
| 10% least volatile stocks in SE Market | 3.2% |
Stable Share Price: SCIB's share price has been volatile over the past 3 months compared to the Swedish market.
Volatility Over Time: SCIB's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 28 | Pia Renaudin | scibase.com |
SciBase Holding AB (publ), a medical technology company, develops and sells point-of-care platforms that utilizes electrical impedance spectroscopy for the evaluation of skin disorders in Europe, the United States, North America, Asia, Oceania, and internationally. It operates through Skin Cancer and Skin Barrier Assessment segments. The company offers Nevisense and Nevisense Go point-of-care platforms to detect melanoma and non-melanoma skin cancer; and assess skin barrier and inflammation.
SciBase Holding AB (publ) Fundamentals Summary
| SCIB fundamental statistics | |
|---|---|
| Market cap | SEK 104.50m |
| Earnings (TTM) | -SEK 59.24m |
| Revenue (TTM) | SEK 25.71m |
4.1x
P/S Ratio-1.8x
P/E RatioIs SCIB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SCIB income statement (TTM) | |
|---|---|
| Revenue | SEK 25.71m |
| Cost of Revenue | SEK 7.71m |
| Gross Profit | SEK 18.00m |
| Other Expenses | SEK 77.24m |
| Earnings | -SEK 59.24m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 12, 2024
| Earnings per share (EPS) | -0.27 |
| Gross Margin | 70.02% |
| Net Profit Margin | -230.41% |
| Debt/Equity Ratio | 0% |
How did SCIB perform over the long term?
See historical performance and comparison